Agilus Diagnostics files DRHP with SEBI

30 Sep 2023 Evaluate

Agilus Diagnostics has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise funds through an initial public offering (IPO).

The IPO is entirely an offer for sale (OFS) of 1.42 crore equity shares by International Finance Corp, NYLIM Jacob Balls India Fund III LLC, and Resurgence PE Investments. ICICI Securities, Axis Capital, and Citigroup Global Markets India are the book-running lead managers to the issue.

Agilus Diagnostic is a diagnostics company based in India providing diagnostic services in pathology and radiology.


© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.